About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Dallas | 559 Studies

Clinical Trials Breast CancerDallas

Breast Cancer Clinical Trials in Dallas

Find 559 clinical trials for breast cancer near Dallas, Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 121-140 of 559 trials

TerminatedA Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid TumorsThe purpose of this study is to evaluate the maximum tolerated dose (MTD) or recommended Phase 2 dose (RP2D), safety and efficacy of TAK-659 in combination with nivolumab in…NCT02834247·La Jolla, California and 21 others CompletedRadiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving SurgeryRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells.NCT01082211·Peoria, Arizona and 57 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsThis study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid…NCT07488676·Birmingham, Alabama and 33 others

Active not recruitingA Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast CancerThis study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called…NCT03975647·Mobile, Alabama and 489 others

CompletedEpothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerThe purpose of this clinical research study is to learn if BMS-247550 added to the approved therapy of capecitabine (Xeloda) provides measurable clinical benefits over…NCT00082433·Tucson, Arizona and 185 others

CompletedProspective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM)This is a prospective registry trial to determine the outcomes of single port robot-assisted nipple sparing mastectomy (SPrNSM) utilitzing the SP da Vinci surgical system.NCT04866992·Dallas, Texas

Active not recruitingStandard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and SurgeryThis randomized phase III trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have undergone surgery.NCT01872975·Birmingham, Alabama and 513 others

RecruitingASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerThe Substudy Protocol ASPEN-09-03 is a Phase 2, single-arm, multicenter study evaluating the efficacy, safety, and tolerability of evorpacept in combination with trastuzumab and…NCT07007559·Phoenix, Arizona and 60 others

RecruitingA Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast CancerThe goal of this clinical study is to learn more about the study drug sacituzumab govitecan-hziy (SG) given at an alternative dose and schedule, in participants with…NCT06926920·Los Angeles, California and 15 others

RecruitingMammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesThe FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry.NCT03053193·Birmingham, Alabama and 133 others

TerminatedTrilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)This was a study to investigate the potential clinical benefit of trilaciclib (G1T28) in preserving the bone marrow and the immune system, and enhancing chemotherapy antitumor…NCT02978716·Tucson, Arizona and 53 others

CompletedUsing Hyperpolarized [1-13C]Pyruvate to Detect CardiotoxicityThe anthracycline doxorubicin, first introduced in the 1960's, continues to be an effectively utilized antineoplastic drug.NCT03685175·Dallas, Texas

CompletedCare Coordination for Complex Cancer Survivors in an Integrated Safety Net SystemNearly 70% of people living with cancer are "complex patients" with multiple chronic conditions who must deal not only with effects of their cancer but also continuing diseases…NCT02943265·Dallas, Texas

CompletedStudy of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.Tinostamustine (EDO-S101) is a first-in-class alkylating deacetylase inhibitor designed to improve drug access to deoxyribonucleic acid (DNA) strands, induce DNA damage and…NCT03345485·Los Angeles, California and 12 others

CompletedEverolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or AnastrozoleThere are no treatments specifically approved after recurrence or progression on a non steroidal aromatase inhibitors (NSAI).NCT00863655·Chandler, Arizona and 199 others

CompletedA First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast CancerThis is a phase I, open-label study of D-0502 single agent and D-0502 in combination with standard dose of palbociclib to assess the safety and tolerability, identify an MTD…NCT03471663·Fresno, California and 14 others

RecruitingA Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerThis is a Phase I/II, multi-site, open-label, two-part study designed to evaluate the efficacy, safety, optimized dose and contribution of components of BNT323 (also known as…NCT06827236·Beverly Hills, California and 83 others

CompletedABI-007 In Combination With Bevacizumab in Women With Metastatic Breast CancerThe purpose of this study is to evaluate the safety and tolerability of weekly ABI-007 in combination with bevacizumab.NCT00394082·Melbourne, Florida and 19 others

CompletedDigital Mammography Screening Trial (ACRIN6652)RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for cancer.NCT00008346·Los Angeles, California and 31 others

CompletedA Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid TumorsThis is a phase 1/2, open-label, multi-center, first-in-human, two-stage (Part 1: dose escalation and Part 2: dose expansion) study evaluating multiple doses and schedules of…NCT05082610·Duarte, California and 5 others

PreviousPage 7 of 28Next

Other Conditions in Dallas

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma